Pomerantz LLP is investigating claims on behalf of investors of Valneva SE (“Valneva” or the “Company”) (NASDAQ: VALN).Such investors are advised to contact Danielle Peyton at newaction@pomlaw.comor 646-581-9980, ext.7980. https://mma.prnewswire.com/media/2287619/Pomerantz_V3_Logo.jpg The investigation concerns whether Valneva and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for […]

Pomerantz LLP is investigating claims on behalf of investors of EHang Holdings Limited (“EHang” or the “Company”) (NASDAQ: EH).Such investors are advised to contact Danielle Peyton at newaction@pomlaw.comor 646-581-9980, ext.7980. https://mma.prnewswire.com/media/2287619/Pomerantz_V3_Logo.jpg The investigation concerns whether EHang and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here

Pomerantz LLP is investigating claims on behalf of investors of Skillz Inc. (“Skillz” or the “Company”) (NYSE: SKLZ). Such investors are advised to contact Danielle Peyton atnewaction@pomlaw.comor 646-581-9980, ext.7980. https://mma.prnewswire.com/media/2287619/Pomerantz_V3_Logo.jpg The investigation concerns whether Skillz and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for

Pomerantz LLP is investigating claims on behalf of investors ofCybin Inc. (“Cybin” or the “Company”)(NYSE: CYBN).Such investors are advised to contact Danielle Peyton atnewaction@pomlaw.comor 646-581-9980, ext.7980. https://mma.prnewswire.com/media/2287619/Pomerantz_V3_Logo.jpg The investigation concerns whetherCybin and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the

Pomerantz LLP is investigating claims on behalf of investors of Agios Pharmaceuticals, Inc. (“Agios” or the “Company”) (NASDAQ: AGIO). Such investors are advised to contact DaniellePeyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. https://mma.prnewswire.com/media/2287619/Pomerantz_V3_Logo.jpg The investigation concerns whetherAgiosand certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here

The DJS Law Group reminds investors of a class action lawsuit against Alto Neuroscience, Inc. (“Alto ” or “the Company”) (NYSE: ANRO ) for violations of the federal securities laws. Shareholders who purchased shares of Alto during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments. Appointment as lead

Most Popular Legal Steroids for Muscle Building from CrazyBulk: Best Selling Steroid Alternatives for Muscle Growth and Cutting in 2025 GlobeNewswire September 08, 2025 New York City, NY, Sept. 08, 2025 (GLOBE NEWSWIRE) — Introduction: What are the best legal steroid alternatives for muscle growth and fat loss from Crazybulk's supplement range. In 2025, demand

SAN FRANCISCO, Sept. 08, 2025 (GLOBE NEWSWIRE) — A New York federal court has re-opened the lead plaintiff process in the Spectrum Pharmaceuticals (SPPI) securities class action. This development offers a new opportunity for investors to represent the class after the previously appointed lead plaintiff was disqualified on August 4, 2025. The new deadline to

Spectrum (SPPI) Securities Lawsuit Seeks New Lead Plaintiff – Hagens Berman GlobeNewswire September 08, 2025 SAN FRANCISCO, Sept. 08, 2025 (GLOBE NEWSWIRE) — A New York federal court has re-opened the lead plaintiff process in the Spectrum Pharmaceuticals (SPPI) securities class action. This development offers a new opportunity for investors to represent the class after

(NYSE:SOC), SAN FRANCISCO, Sept. 08, 2025 (GLOBE NEWSWIRE) — A newly filed class-action lawsuit targets Sable Offshore Corp. (NYSE: SOC) and its executives, alleging the company misrepresented its oil production status to investors. The litigation, filed in federal court in California, claims the company used a misleading press release to artificially inflate its stock price